Kursinformationen zu State Street® SPDR® S&P® Pharmaceuticals ETF
- NAV in CHF
- 66.81
- Tagesveränderung relativ
- +0.96%
- Tagesveränderung absolut
- 0.64
- NAV Vortag
- 66.17
- Letzter Handel
- 28.09.2026
- Ausgabekommissionen
- +0.00%
- Verwaltungsgebühr
- +0.35%
- OGC
- 0.00 %
- Monatsbericht
- -
- Halbjahresbericht
- -
- Jahresbericht
- -
- Vollständiger Prospekt
- -
- Gesetzl. Publikationen
- -
The State Street SPDR S&P Pharmaceuticals ETF (the "Fund") seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. Instead, the Fund may purchase a subset of the securities in the Index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the Index. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. Based on its analysis of these factors, SSGA Funds Management, Inc. ("SSGA FM" or the "Adviser"), the investment adviser to the Fund, either may invest the Fund's assets in a subset of securities in the Index or may invest the Fund's assets in substantially all of the securities represented in the Index in approximately the same proportions as the Index, as determined by the Adviser to be in the best interest of the Fund in pursuing its objective.
| Zeitraum | Performance | Volatilität | Sharpe Ratio | Bester Monat | Schlecht. Monat | Max Verlust |
|---|---|---|---|---|---|---|
| YTD | +19.44% | +23.01% | +1.06% | +13.99% | -5.85% | -11.78% |
| 6 Monate | +30.17% | +23.36% | +2.87% | +13.99% | -5.85% | -10.64% |
| 1 Jahr | +41.30% | +22.31% | +1.74% | +13.99% | -5.85% | -11.78% |
| 3 Jahre | +72.03% | +20.29% | +0.85% | +14.97% | -9.85% | -23.45% |
| 5 Jahre | - | - | - | +14.97% | -9.85% | - |
- ISIN
- US78464A7220
- Valor
- -
- Währung
- USD
- Anlageklasse
- Alternative Investm.
- UCITS
- nein
- Branche
- ETF Aktien
- Anlageregion
- -
- Domizil
- USA
- Vertriebszulassung
- USA
- Auflagedatum
- 19.06.2006
- Volumen
- 544'496'695.52
- Geschäftsjahresbeginn
- 01.07.2026
- Depotbank
- State Street Global Advisors
- Emittent
- SSGA FM
- Amylyx Pharmaceuticals Inc.
- 3.65 %
- Crinetics Pharmaceuticals Inc.
- 3.60 %
- Omeros Corp.
- 2.68 %
- Enliven Therapeutics Inc.
- 2.28 %
- Nuvation Bio Inc.
- 2.12 %
- Corcept Therapeutics Inc.
- 2.11 %
- Eton Pharmaceuticals Inc.
- 2.08 %
- Perrigo Co. PLC
- 1.91 %
- Edgewise Therapeutics Inc.
- 1.85 %
- Merck & Co. Inc.
- 1.81 %
- Gesundheitswesen
- 78.17 %